

|
Taiwan's Academia Sinica and the Seattle-based Infectious Disease Research Institute signed an agreement yesterday to jointly develop new medications for drug-resistant strains of tuberculosis.
|
|
Jakko van Ingen, Dick van Soolingen, Rob Slingerland, Willem D.H. Hendriks, and Jan G. den Hollander Author affililiations: Maasstad Ziekenhuis Rotterdam, Rotterdam, the Netherlands ; and National Institute for Public Health and the Environment, Bilthoven, the Netherlands To the Editor: Mycobacterium haemophilum is an aerobic, slow-growing ...
|
|
Discriminatory Ability of Hypervariable Variable Number Tandem Repeat Loci in Population-based Analysis of Mycobacterium tuberculosis Strains, London, UK Author affiliations: Barts and The London School of Medicine, Queen Mary, University of London, London, UK ; and Health Protection Agency National Mycobacterium Reference Laboratory, London ...
|
|
Tuberculosis is a condition generally affecting the lungs. This condition is caused by bacterial infection from mycobacterium tuberculosis, of which the symptoms include: coughing , chest pains, weakness, weight loss, night sweats and fever, however it can also cause no symptoms as the body is able to fight off the bacteria.
|
|
The proteasome - the cell's garbage disposal for proteins - could become a target for new tuberculosis drugs, biologists report.
|
|
Cases of multidrug-resistant tuberculosis in Victoria rose between 1998 and 2007, data published in the Medical Journal of Australia has revealed.
|
|
Every year nearly ten million people develop tuberculosis , a contagious infection, usually of the lungs.
|
|
Researchers in the US have discovered that a class of small molecules can selectively disable a key protein complex in the tuberculosis bacterium and kill the organism, raising the possibility of new highly selective drugs to treat tuberculosis.
|
|
Tuberculosis is a global threat that affects more than 10 million people each year.
|